More Americans died in 2007 of hepatitis C infection, which causes incurable liver disease, than from the virus that causes AIDS, US health authorities said this week.
Thứ Sáu, 24 tháng 2, 2012
Thứ Năm, 23 tháng 2, 2012
US health experts give nod to new obesity drug
A new drug to treat advanced skin cancer, or metastatic melanoma, has been shown to nearly double average survival time in a study of more than 130 patients, researchers said Wednesday.
Thứ Hai, 13 tháng 2, 2012
Illicit Drugs Bought Off Internet May Be Poisons, Experts Warn
The case study appears in the Feb. 10 issue of the Morbidity and Mortality Weekly Report, which is published by the U.S. Centers for Disease Control and Prevention.
The term "research chemicals" is a phrase used to illegally sell stimulants on the Internet, to avoid regulations that ban their use, the report authors said.
The authors described the case of two Oregon men who believed they had bought the designer amphetamine derivative 2C-E online. But the product they actually received was aniline, a highly toxic industrial chemical.
Even though these research chemicals all carry a warning label that they are "not for human consumption," the two men ingested the chemical. They quickly suffered a severe reaction as their hemoglobin was converted to methemoglobin, a molecule that prevents red blood cells from carrying oxygen.
The men's skin turned blue due to the lack of oxygen in their blood and one of them lost consciousness, said report author Dr. Shana Kusin and colleagues from the Oregon Poison Center.
The men were saved after poison center and health department officials rapidly identified the chemical and the proper treatment.
The incident illustrates the potentially life-threatening risks of buying so-called "research chemicals" over the Internet, the report authors concluded.
More information
The U.S. National Institute on Drug Abuse has more about drug abuse and addiction.
Thứ Ba, 7 tháng 2, 2012
Neuroscience the new face of warfare: experts
Rapid progress in the ability to map brain activity and manipulate its responses with stimulants could change the face of warfare, a panel of experts said on Tuesday.
The experts, looking at the scope for neuroscience in future military conflict, said researchers on the cutting edge of medical science should remember that their work could have other, more harmful uses.
"We know neuroscience research has the potential to deliver great social benefit - researchers come closer every day to finding effective treatments for diseases and disorders such as Parkinson's, depression, schizophrenia, epilepsy and addiction," said Rod Flower, a professor of biochemical pharmacology at Queen Mary University of London, who led the panel.
"However, understanding of the brain and human behavior, coupled with developments in drug delivery, also highlight ways of degrading human performance that could possibly be used in new weapons."
The report, published on Tuesday by the UK's national academy of science, the Royal Society, was written by experts in neuroscience, international security, psychology and ethics.
It divided the issue of neuroscience in conflict and security into two main areas - the potential to enhance performance of military forces, and the potential to degrade or diminish the enemy's performance.
Looking at performance enhancement, the report pointed to advances in neural interface technologies which could allow machines such as drone aircraft to be controlled directly with the human brain, and advances in neuroimaging which could help military chiefs screen for recruits with particular attributes.
"There is also a great deal of research taking place around drugs that improve the alertness, attention and memory of military personnel while in the field," the report said.
The experts said it was in the interests of military commanders to screen for abilities relevant to a given task.
While one person may excel in detecting targets in a cluttered environment, they said, another might excel in decision making skills under stress, and advances in neuroimaging and brain stimulation techniques could help pinpoint these differences during screening and recruitment.
Irene Tracey, an expert on brain imaging from Oxford University and one of the report's authors, said most of the applications of neural interface technology, such as brain prostheses or implants, have so far been only at the trial stage and mostly in medicine - particularly involving the rehabilitation of people using prosthetic limbs.
"You can imagine how you can be used for the military - both for rehabilitation of soldiers and for control of remote devices," she told a briefing in London. "Some of it is the stuff of dreams at this stage, but the speed at which technologies tend develop ... is always alarmingly quick."
MIND AND MACHINE
Flower gave an example of how an aircraft like a drone could be in future be controlled by a person with such brain implant - raising tricky ethical questions.
"This idea brings about a bit of a blur in the distinction between mind and machine, which obviously has to be addressed very carefully," he said. "If we got to the point where we could control a sophisticated machine, and the machine did something ... like committing a war crime of some sort, who would be responsible for that, you or the machine?"
The report also looked at neuroscientific applications that could give rise to new weapons - particularly advances in neuropharmacology and drug delivery that could speed the development of incapacitating chemical agents.
The report highlighted new so-called directed energy weapons in development, including one called an Active Denial System (ADS) which uses a millimeter wave beam to heat the skin and cause a painful burning sensation.
Malcom Dando, a professor of international security at the University of Bradford and another of the authors, said the changes neuroscience could bring about were mostly in the future, giving experts time to assess their impact.
"We're only at the beginning of a whole stream of neuroscience applications, and that gives us a window of opportunity to weigh up the pros and cons," he said.
(Reporting by Kate Kelland; Editing by Andrew Heavens)